艾塞那肽治疗肥胖症的机制研究(5)
[13] Sansbury BE， Hill BG. Regulation of obesity and insulin resistance by nitric oxide. Free Radic Biol Med， 2014，73：383-399.
[14] 冯文雯，潘幸，周昭远.男性肥胖型与非肥胖型OSAHS和胰岛素抵抗的相关分析.新医学， 2015， 46(10)：677-681.
[15] Ryan S. Adipose tissue inflammation by intermittent hypoxia： mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol， 2017， 595(8)：2423-2430.
[16] Murphy AM， Thomas A， Crinion SJ， Kent BD， Tambuwala MM， Fabre A， Pepin JL， Roche HM， Arnaud C， Ryan S. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J， 2017， 49(4)：1601731.
[17] Perrini S， Cignarelli A， Quaranta VN， Falcone VA， Kounaki S， Porro S， Ciavarella A， Ficarella R， Barbaro M， Genchi VA， Nigro P， Carratù P， Natalicchio A， Laviola L， Resta O， Giorgino F. Correction of intermittent hypoxia reduces inflam-mation in obese subjects with obstructive sleep apnea. JCI Insight， 2017， 2(17)：e94379.
(收稿日期：2020-02-29)
(本文編辑：林燕薇), http://www.100md.com(叶志伟?冼颖欣?陈宗兰?林倍思?徐芬?姚斌)
[14] 冯文雯，潘幸，周昭远.男性肥胖型与非肥胖型OSAHS和胰岛素抵抗的相关分析.新医学， 2015， 46(10)：677-681.
[15] Ryan S. Adipose tissue inflammation by intermittent hypoxia： mechanistic link between obstructive sleep apnoea and metabolic dysfunction. J Physiol， 2017， 595(8)：2423-2430.
[16] Murphy AM， Thomas A， Crinion SJ， Kent BD， Tambuwala MM， Fabre A， Pepin JL， Roche HM， Arnaud C， Ryan S. Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J， 2017， 49(4)：1601731.
[17] Perrini S， Cignarelli A， Quaranta VN， Falcone VA， Kounaki S， Porro S， Ciavarella A， Ficarella R， Barbaro M， Genchi VA， Nigro P， Carratù P， Natalicchio A， Laviola L， Resta O， Giorgino F. Correction of intermittent hypoxia reduces inflam-mation in obese subjects with obstructive sleep apnea. JCI Insight， 2017， 2(17)：e94379.
(收稿日期：2020-02-29)
(本文編辑：林燕薇), http://www.100md.com(叶志伟?冼颖欣?陈宗兰?林倍思?徐芬?姚斌)